Michael Patrick Guest
← all tradesR · U.S. House · MS03
64 disclosed stock trades on file across 43 tickers · traded 2020-02-21 to 2026-07-02 · latest disclosure 2026-08-13. Reported under the STOCK Act. Amounts are the disclosed ranges, not exact values; “lag” is days from trade to disclosure. As disclosed — not investment advice. methodology → sources →
Michael Patrick GuestRHouse · MS03· estimated positions — what they still seem to hold methodology → sources →
← all tradesWho's trading this portfolioshare of disclosed $ volume · range midpoints
Member 15%Spouse 79%Dependent 7%
85% of this member's disclosed volume is a spouse, joint or dependent account — on the member's filing, not necessarily traded by them.
Disclosed trades
most recent first · the 10 most recent disclosures
| Ticker | Type | Amount | Trade date | Disclosed | Lag |
|---|---|---|---|---|---|
| ELFSP | SELL | $1,001–$15,000 | 2025-12-16 | 2026-08-13 | 240d |
| CVXSP | SELL | $1,001–$15,000 | 2025-12-16 | 2026-08-13 | 240d |
| ABNBSP | SELL | $1,001–$15,000 | 2025-12-16 | 2026-08-13 | 240d |
| XOMSP | EXCHANGE | $1,001–$15,000 | 2026-07-02 | 2026-08-04 | 33d |
| XOMSP | EXCHANGE | $1,001–$15,000 | 2026-07-02 | 2026-08-04 | 33d |
| OTCMSP | SELL | $1,001–$15,000 | 2026-01-09 | 2026-02-04 | 26d |
| EVVTYSP | SELL | $1,001–$15,000 | 2026-01-09 | 2026-02-04 | 26d |
| DTSP | SELL | $1,001–$15,000 | 2026-01-09 | 2026-02-04 | 26d |
| CHRDSP | SELL | $1,001–$15,000 | 2026-01-09 | 2026-02-04 | 26d |
| MPWRDC | BUY | $1,001–$15,000 | 2025-10-20 | 2025-11-05 | 16d |
Showing the 10 most recent of 64 disclosed trades — sign in free to see more. Create a free account →See it live on AAPL →
Filings on paper
The House publishes these reports as scanned images. Each link opens the filing on the Clerk's own site.
2023
Filed 2023-08-11view at the House Clerk →
2019
Filed 2019-11-06view at the House Clerk →
Filed 2019-07-17view at the House Clerk →
Related· who else trades these names
Related· executive-branch officials who also traded these names
A model's estimate — for research. See the Disclaimer.